Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies

NCT07644039 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

119

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignancies

Interventions

DRUG: Pembrolizumab
DRUG: PM54

Sponsor

PharmaMar